[{"from": "human", "value": "Describe this molecule. [C][O][C][=Branch1][C][=O][N][C][=C][Branch2][Ring2][Ring1][N][=C][Branch1][=Branch1][N][=C][Ring1][=Branch1][N][C][=N][N][Branch1][O][C][=C][Ring1][Branch1][C][=C][C][=N][Ring1][=Branch1][C][C][=C][C][=C][C][=C][Ring1][=Branch1][F][N]"}, {"from": "gpt", "value": "The molecule is a member of the class of pyrazolopyridines that is 1H-pyrazolo[3,4-b]pyridine which is substituted by a 2-fluorobenzyl and 4,6-diamino-5-[(methoxycarbonyl)amino]pyrimidin-2-yl groups at positions 1 and 3, respectively. It is an active metabolite of riociguat and a soluble guanylate cyclase stimulator developed by Bayer for the treatment of erectile dysfunction and heart failure. It has a role as a soluble guanylate cyclase activator, an antihypertensive agent, a drug metabolite and a vasodilator agent. It is a pyrazolopyridine, a member of monofluorobenzenes, a carbamate ester and an aminopyrimidine."}]